1537 related articles for article (PubMed ID: 8257447)
1. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
[TBL] [Abstract][Full Text] [Related]
2. Pravastatin modulates cholesteryl ester transfer from HDL to apoB-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia.
Guérin M; Dolphin PJ; Talussot C; Gardette J; Berthézène F; Chapman MJ
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1359-68. PubMed ID: 7670950
[TBL] [Abstract][Full Text] [Related]
3. Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles.
Guerin M; Lassel TS; Le Goff W; Farnier M; Chapman MJ
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):189-97. PubMed ID: 10634817
[TBL] [Abstract][Full Text] [Related]
4. Interaction between high-density lipoprotein subpopulations in apo B-free and abetalipoproteinemic plasma.
Cheung MC; Wolf AC; Illingworth DR
Biochim Biophys Acta; 1992 Oct; 1128(2-3):244-9. PubMed ID: 1420297
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of triphasic oral contraceptives with desogestrel or levonorgestrel on apolipoprotein A-I-containing high-density lipoprotein particles.
Cheung MC; Walden CE; Knopp RH
Metabolism; 1999 May; 48(5):658-64. PubMed ID: 10337871
[TBL] [Abstract][Full Text] [Related]
6. Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin.
Contacos C; Barter PJ; Vrga L; Sullivan DR
Atherosclerosis; 1998 Nov; 141(1):87-98. PubMed ID: 9863541
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
8. Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin.
Lijnen P; Celis H; Desager JP; Fagard R
J Hum Hypertens; 1995 Jul; 9(7):557-64. PubMed ID: 7562885
[TBL] [Abstract][Full Text] [Related]
9. Effect of the human cholesteryl ester transfer protein on the particle size redistribution of specific subpopulations of high density lipoproteins-3.
Lagrost L
Biochim Biophys Acta; 1992 Jun; 1126(2):143-50. PubMed ID: 1627616
[TBL] [Abstract][Full Text] [Related]
10. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects.
Ambrosch A; Mühlen I; Kopf D; Augustin W; Dierkes J; König W; Luley C; Lehnert H
Diabetes Care; 1998 Dec; 21(12):2077-84. PubMed ID: 9839097
[TBL] [Abstract][Full Text] [Related]
11. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
[TBL] [Abstract][Full Text] [Related]
12. Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.
Cheung MC; Mendez AJ; Wolf AC; Knopp RH
J Clin Invest; 1993 Feb; 91(2):522-9. PubMed ID: 8432861
[TBL] [Abstract][Full Text] [Related]
13. Effects of vitamin E and HMG-CoA reductase inhibition on cholesteryl ester transfer protein and lecithin-cholesterol acyltransferase in hypercholesterolemia.
Napoli C; Leccese M; Palumbo G; de Nigris F; Chiariello P; Zuliani P; Somma P; Di Loreto M; De Matteis C; Cacciatore F; Abete P; Liguori A; Chiariello M; D'Armiento FP
Coron Artery Dis; 1998; 9(5):257-64. PubMed ID: 9710685
[TBL] [Abstract][Full Text] [Related]
14. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects.
Lagrost L; Gandjini H; Athias A; Guyard-Dangremont V; Lallemant C; Gambert P
Arterioscler Thromb; 1993 Jun; 13(6):815-25. PubMed ID: 8499401
[TBL] [Abstract][Full Text] [Related]
15. Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity.
Kahri J; Vuorinen-Markkola H; Tilly-Kiesi M; Lahdenperä S; Taskinen MR
Atherosclerosis; 1993 Aug; 102(1):79-89. PubMed ID: 8257455
[TBL] [Abstract][Full Text] [Related]
16. Conversion of apolipoprotein-specific high-density lipoprotein populations during incubation of human plasma.
Nichols AV; Blanche PJ; Shore VG; Gong EL
Biochim Biophys Acta; 1989 Feb; 1001(3):325-37. PubMed ID: 2492827
[TBL] [Abstract][Full Text] [Related]
17. Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.
Bard JM; Parra HJ; Douste-Blazy P; Fruchart JC
Metabolism; 1990 Mar; 39(3):269-73. PubMed ID: 2106607
[TBL] [Abstract][Full Text] [Related]
18. Familial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis.
Forte TM; Nichols AV; Krauss RM; Norum RA
J Clin Invest; 1984 Nov; 74(5):1601-13. PubMed ID: 6501564
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cholesteryl ester transfer protein in normocholesterolemic and hypercholesterolemic hamsters: effects on HDL subspecies, quantity, and apolipoprotein distribution.
Evans GF; Bensch WR; Apelgren LD; Bailey D; Kauffman RF; Bumol TF; Zuckerman SH
J Lipid Res; 1994 Sep; 35(9):1634-45. PubMed ID: 7806977
[TBL] [Abstract][Full Text] [Related]
20. Influence of cholesterol-lowering on plasma membrane lipids and function.
Lijnen P; Echevaría-Vázquez D; Petrov V
Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]